← Open Payments lookup

MEHRZAD SERAJI: Open Payments

NPI 1942539085 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,337 in 59 payments from 19 companies in 2025. Trend: 2023 $630 · 2024 $746 · 2025 $1,337

Food & beverage: $1,226Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$182
ABBVIE INC.6$160
Teva Pharmaceuticals USA, Inc.4$155
Supernus Pharmaceuticals, Inc.5$114
Alkermes, Inc.5$113
Axsome Therapeutics, Inc.5$95
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$83
Janssen Pharmaceuticals, Inc2$77
Otsuka America Pharmaceutical, Inc.3$65
Collegium Pharmaceutical, Inc.2$43

Products named: INGREZZA, VRAYLAR, Qelbree, ARISTADA, Auvelity, CAPLYTA, REXULTI, INVEGA SUSTENNA.

Industry payments across MO — which companies pay providers there.